(Q34240036)

31 July 2017

Improving outcome of treatment of kala-azar by supplementation of amphotericin B with physiologic saline and potassium chloride (English)

1 reference

31 July 2017

visceral leishmaniasis

1 reference

1 reference

1 reference

Chandeshwar P Thakur

1

1 reference

31 July 2017

A Kumar

2

1 reference

31 July 2017

Dipendra K Mitra

3

1 reference

31 July 2017

Ambak Roy

4

1 reference

31 July 2017

Arun Kumar Sinha

5

1 reference

31 July 2017

Alok Ranjan

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

American Journal of Tropical Medicine and Hygiene

31 July 2017

1 reference

31 July 2017

83

1 reference

31 July 2017

1040-1043

1 reference

31 July 2017

5

1 reference

Injectable paromomycin for Visceral leishmaniasis in India

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963966

Advances in the treatment of leishmaniasis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963966

Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963966

Comparison of regimens of amphotericin B deoxycholate in kala-azar.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963966

Administering amphotericin B--a practical approach

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963966

Correction of serum electrolyte imbalance prevents cardiac arrhythmia during amphotericin B administration

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963966

Amphotericin B: 30 years of clinical experience

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963966

Amphotericin B for second-line treatment of Indian kala-azar

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963966

Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963966

A new strategy for elimination of kala-azar from rural Bihar.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963966

IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963966

Visceral leishmaniasis - current therapeutic modalities.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963966

Determining the sample size in a clinical trial.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963966

Use of amphotericin B in drug-resistant cases of visceral leishmaniasis in north Bihar, India.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963966

Evidence that the High Incidence of Treatment Failures in Indian Kala‐Azar Is Due to the Emergence of Antimony‐Resistant Strains ofLeishmania donovani

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963966

A pharmacologic guide to the clinical use of amphotericin B

28 October 2018

1 reference

12 December 2020

Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis

1 reference

12 December 2020

Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates

1 reference

12 December 2020

Evaluation of amphotericin B as a first line drug in comparison to sodium stibogluconate in the treatment of fresh cases of kala-azar

1 reference

12 December 2020

Diagnosis of symptomatic visceral leishmaniasis by use of the polymerase chain reaction on patient blood

1 reference

12 December 2020

Sodium antimony gluconate, amphotericin, and myocardial damage

1 reference

12 December 2020

TREATMENT OF KALA-AZAR WITH AMPHOTERICIN B

1 reference

12 December 2020

Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis

1 reference

12 December 2020

10.4269/AJTMH.2010.10-0255

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference